Augmentation of natural immunity to a pro-inflammatory cytokine (TNF-alpha) by targeted DNA vaccine confers long-lasting resistance to experimental autoimmune encephalomyelitis
- 1 June 1999
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (6) , 1128-1138
- https://doi.org/10.1038/sj.gt.3300915
Abstract
TNF-α is thought to be a key pro-inflammatory cytokine in T cell-mediated autoimmune diseases, particularly in rheumatoid arthritis (RA) and multiple sclerosis (MS). Experimental autoimmune encephalomyelitis (EAE) serves as an animal model for MS. The current study observes a notable TNF-α-specific antibody titer generated during the course of EAE, apparently not sufficient to prevent the development of disease. Administration of TNF-α-naked DNA vaccine enhanced the production of TNF-α-specific antibody titer and conferred EAE resistance. These antibodies were found to be neutralizing in vitro and capable of inhibiting the development of disease when transferred to other EAE rats. Thus, modulation of EAE with TNF-α DNA vaccines enhances the regulation of natural immunity to a self pro-inflammatory cytokine and provides a tool by which the immune system is encouraged to elicit anti-self protective immunity to restrain its own harmful reactivity when such a response is needed.Keywords
This publication has 95 references indexed in Scilit:
- The immune system evolved to discriminate infectious nonself from noninfectious selfPublished by Elsevier ,2003
- Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous systemEuropean Journal of Immunology, 1997
- Antigen-Induced Programmed T Cell Death as a New Approach to Immune TherapyClinical Immunology and Immunopathology, 1995
- Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseasesImmunology Today, 1995
- Published by American Association for the Advancement of Science (AAAS) ,1994
- T Cell Deletion in High Antigen Dose Therapy of Autoimmune EncephalomyelitisScience, 1994
- Interleukin-12 and its role in the generation of TH1 cellsImmunology Today, 1993
- From Antilymphocyte Serum to Therapeutic Monoclonal Antibodies: First Experiences with a Chimeric CD4 Antibody in the Treatment of Autoimmune DiseaseImmunological Reviews, 1992
- The role of IL-10 in crossregulation of TH1 and TH2 responsesImmunology Today, 1991
- Multiple SclerosisNew England Journal of Medicine, 1982